Advanced immunoassays and inflammation models
Our immunology team has developed an advanced immunoassay and inflammation platform that provides cutting-edge preclinical in vitro and in vivo/ex vivo models. Our scientists utilise comprehensive immunophenotyping, as well as biomarkers with pharmacodynamic, predictive and surveillance utility to accelerate the discovery, characterisation and optimisation of treatments and drug targets. This comprehensive approach enhances your immunology research and development initiatives across a broad range of therapeutic areas, including oncology, inflammation, cardiology and neurology.




